APA (7th ed.) Citation

Iwama, E., Sakai, K., Azuma, K., Harada, T., Harada, D., Nosaki, K., . . . Okamoto, I. (2017). Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations. Annals of Oncology, 28(1), 136. https://doi.org/10.1093/annonc/mdw531

Chicago Style (17th ed.) Citation

Iwama, E., et al. "Monitoring of Somatic Mutations in Circulating Cell-free DNA by Digital PCR and Next-generation Sequencing During Afatinib Treatment in Patients with Lung Adenocarcinoma Positive for EGFR Activating Mutations." Annals of Oncology 28, no. 1 (2017): 136. https://doi.org/10.1093/annonc/mdw531.

MLA (9th ed.) Citation

Iwama, E., et al. "Monitoring of Somatic Mutations in Circulating Cell-free DNA by Digital PCR and Next-generation Sequencing During Afatinib Treatment in Patients with Lung Adenocarcinoma Positive for EGFR Activating Mutations." Annals of Oncology, vol. 28, no. 1, 2017, p. 136, https://doi.org/10.1093/annonc/mdw531.